Document is current

Article History

Received: 30 October 2021

Accepted: 31 May 2022

First Online: 6 June 2022

Declarations

:

: The World Health Organization’s ethical and safety recommendations for exploring sensitive topics were observed, and all methods were performed following the relevant guidelines and regulations. We received ethical approval from the Institutional Review Committee (Ref No-RP/366/10) of Debre Tabor University [CitationRef removed]. The WHO guidelines for conducting violence against women research [CitationRef removed] were also followed. Information about the study was given, and well-versed written informed consent was obtained from all study participants. Similarly, written permission was approved to record the conversation. To uphold the seclusion, anonymity, and confidentiality of data, we explained to the respondents that their identity and the evidence they would provide would be secret. The participants further clarified that only the researchers were directly involved in this study. Confidentiality was maintained after the data was collected by de-identifying and keeping the field notes, transcripts, and audio recordings. The researcher used generic terms in this article, such as study participants and female workers, instead of their names. It was explained that there were no ‘right’ or ‘wrong’ answers in that location. The study participants have the right to terminate the interview and withdraw from the subject field. Privacy and confidentiality were ensured in each interview and FGD. Moreover, participants were assured that they could freely discuss the issues without fear of such conversations being monitored by their supervisors.

: Not applicable.

: The authors declare that they have no competing interests.